Please provide your email address to receive an email when new articles are posted on . The onset of the COVID-19 pandemic forced health care systems to adapt clinical practice to limit patient ...
Similar number of out-of-range next INR values for patients with, without extended testing interval (HealthDay News) — For stable warfarin-treated patients, extended international normalized ratio ...
For patients on long-term oral anticoagulation therapy, use of point-of-care devices is associated with lower rates of death and major thromboembolic events compared with laboratory determinations of ...
The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...
Warfarin is an anti-coagulant prescribed to people with various heart conditions and those who have experienced or are at high risk for a blood clot. Anti-coagulants are also referred to as “blood ...
Exemption of the system from virtually all CLIA rules gives more labs access to connectivity and data management capabilities for monitoring patients on warfarin therapy INDIANAPOLIS, Oct. 1, 2012 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback